Literature DB >> 15247268

Plasmin-induced migration requires signaling through protease-activated receptor 1 and integrin alpha(9)beta(1).

Mousumi Majumdar1, Takehiko Tarui, Biao Shi, Nobuaki Akakura, Wolfram Ruf, Yoshikazu Takada.   

Abstract

Plasmin is a major extracellular protease that elicits intracellular signals to mediate platelet aggregation, chemotaxis of peripheral blood monocytes, and release of arachidonate and leukotriene from several cell types in a G protein-dependent manner. Angiostatin, a fragment of plasmin(ogen), is a ligand and an antagonist for integrin alpha(9)beta(1). Here we report that plasmin specifically interacts with alpha(9)beta(1) and that plasmin induces of cells expressing migration recombinant alpha(9)beta(1) (alpha(9)-Chinese hamster ovary (CHO) cells). Migration was dependent on an interaction of the kringle domains of plasmin with alpha(9)beta(1) as well as the catalytic activity of plasmin. Angiostatin, representing the kringle domains of plasmin, alone did not induce the migration of alpha(9)-CHO cells, but simultaneous activation of the G protein-coupled protease-activated receptor (PAR)-1 with an agonist peptide induced the migration on angiostatin, whereas PAR-2 or PAR-4 agonist peptides were without effect. Furthermore, a small chemical inhibitor of PAR-1 (RWJ 58259) and a palmitoylated PAR-1-blocking peptide inhibited plasmin-induced migration of alpha(9)-CHO cells. These results suggest that plasmin induces migration by kringle-mediated binding to alpha(9)beta(1) and simultaneous proteolytic activation of PAR-1.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15247268     DOI: 10.1074/jbc.M401372200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  The lymphangiogenic vascular endothelial growth factors VEGF-C and -D are ligands for the integrin alpha9beta1.

Authors:  Nicholas E Vlahakis; Bradford A Young; Amha Atakilit; Dean Sheppard
Journal:  J Biol Chem       Date:  2004-12-06       Impact factor: 5.157

2.  EMILIN1/α9β1 integrin interaction is crucial in lymphatic valve formation and maintenance.

Authors:  Carla Danussi; Lisa Del Bel Belluz; Eliana Pivetta; Teresa Maria Elisa Modica; Andres Muro; Bruna Wassermann; Roberto Doliana; Patrizia Sabatelli; Alfonso Colombatti; Paola Spessotto
Journal:  Mol Cell Biol       Date:  2013-09-09       Impact factor: 4.272

Review 3.  Pharmacology, biodistribution, and efficacy of GPCR-based pepducins in disease models.

Authors:  Sarah L Tressel; Georgios Koukos; Boris Tchernychev; Suzanne L Jacques; Lidija Covic; Athan Kuliopulos
Journal:  Methods Mol Biol       Date:  2011

4.  Urinary plasmin inhibits TRPV5 in nephrotic-range proteinuria.

Authors:  Kukiat Tudpor; Sergio Laínez; Arjan J Kwakernaak; Nadezda V Kovalevskaya; Sjoerd Verkaart; Siebe van Genesen; Annemiete van der Kemp; Gerjan Navis; René J M Bindels; Joost G J Hoenderop
Journal:  J Am Soc Nephrol       Date:  2012-09-27       Impact factor: 10.121

5.  The role of α9β1 integrin and its ligands in the development of autoimmune diseases.

Authors:  Shigeyuki Kon; Toshimitsu Uede
Journal:  J Cell Commun Signal       Date:  2017-10-03       Impact factor: 5.782

6.  Plasminogen/plasmin modulates bone metabolism by regulating the osteoblast and osteoclast function.

Authors:  Yosuke Kanno; Akira Ishisaki; Eri Kawashita; Naoyuki Chosa; Keiichi Nakajima; Tatsuji Nishihara; Kuniaki Toyoshima; Kiyotaka Okada; Shigeru Ueshima; Kenji Matsushita; Osamu Matsuo; Hiroyuki Matsuno
Journal:  J Biol Chem       Date:  2011-01-14       Impact factor: 5.157

7.  Plasminogen activation/plasmin in rheumatoid arthritis: matrix degradation and more.

Authors:  Martin O Judex; Barbara M Mueller
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

8.  Lymphotoxin-β receptor-NIK signaling induces alternative RELB/NF-κB2 activation to promote metastatic gene expression and cell migration in head and neck cancer.

Authors:  Rita Das; Jamie Coupar; Paul E Clavijo; Anthony Saleh; Tsu-Fan Cheng; Xinping Yang; Jianhong Chen; Carter Van Waes; Zhong Chen
Journal:  Mol Carcinog       Date:  2018-11-28       Impact factor: 4.784

9.  Plasmin enhances cell surface tissue factor activity in mesothelial and endothelial cells.

Authors:  H Kothari; G Kaur; S Sahoo; S Idell; L V M Rao; U Pendurthi
Journal:  J Thromb Haemost       Date:  2008-11-03       Impact factor: 5.824

10.  Plasminogen inhibits TNFalpha-induced apoptosis in monocytes.

Authors:  Jennifer W Mitchell; Nagyung Baik; Francis J Castellino; Lindsey A Miles
Journal:  Blood       Date:  2006-02-14       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.